|
Corrigendum to ‘Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models’ [Eur J Cancer 61 (2016) 20–28] |
|
|
|
Titel: |
Corrigendum to ‘Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models’ [Eur J Cancer 61 (2016) 20–28] |
Auteur: |
Tsimafeyeu, Ilya Ludes-Meyers, John Stepanova, Evgenia Daeyaert, Frits Khochenkov, Dmitry Joose, Jean-Baptiste Solomko, Eliso Van Akene, Koen Peretolchina, Nina Yin, Wei Ryabaya, Oxana Byakhov, Mikhail Tjulandin, Sergei |
Verschenen in: |
European journal of cancer |
Paginering: |
Jaargang 70 (2017) nr. C pagina's 1 p. |
Jaar: |
2017 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|